Berkeley Lights Inc. (BLI) – Press Releases
-
PhenomeX Announces Opto® Memory B Discovery Human Workflow on the Beacon® Optofluidic Platform
-
PhenomeX Announces the Release of SpotLight™ Human Lambda Reagent for the Beacon® Platform to Accelerate Cell Line Development Workflows
-
PhenomeX to Participate in Upcoming Cell Biology Conferences
-
PhenomeX Unveils Meteor™ Chips For Quantitative Bulk Analysis On The IsoSpark™ Platform To Revolutionize High Throughput Multiplexed Hands-Free Proteomics
-
PhenomeX Inc. Announces Commencement of Cash Tender Offer by Bruker
-
Bruker Corporation and PhenomeX Inc. Announce Definitive Agreement for Bruker to Acquire PhenomeX in All-Cash Transaction
-
PhenomeX Reports Second Quarter 2023 Financial Results and Provides Business Update
-
PhenomeX to Report Second Quarter 2023 Financial Results on August 14, 2023
-
PhenomeX Announces Lifting of the Stay in AbCellera Patent Infringement Case
-
PhenomeX's Beacon® Technology Enables Early Identification of Potent Omicron-Neutralizing Antibodies
-
PhenomeX Launches Beacon Quest™ Optofluidic System with Opto® T Cell Profiling Workflows
-
PhenomeX Launches Beacon Select™ Optofluidic System with Opto® B Discovery Workflows
-
PhenomeX Reports First Quarter 2023 Financial Results
-
PhenomeX To Participate in 19th Annual PEGS Boston Conference & Expo
-
PhenomeX to Report First Quarter 2023 Financial Results on May 11, 2023
-
PhenomeX Launches the Opto® T Cell Profiling Workflow
-
PhenomeX Appoints Peter Silvester to PhenomeX Board of Directors
-
PhenomeX to Participate in American Association of Cancer Research Annual Meeting 2023
-
Berkeley Lights Completes Acquisition of IsoPlexis Forming PhenomeX, the Functional Cell Biology Company
-
Berkeley Lights Reports Fourth Quarter and Full Year 2022 Financial Results
-
Berkeley Lights to Report Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023
-
Berkeley Lights Reports Preliminary Full Year 2022 Revenue Results
-
Berkeley Lights Launches Beacon Select™, A New Optofluidic System For Cell Line Development
-
Berkeley Lights to Participate in the 41st Annual J.P. Morgan Healthcare Conference
-
Berkeley Lights to Acquire IsoPlexis, Creating a Premier Functional Cell Biology Company
-
Berkeley Lights to Acquire IsoPlexis, Creating a Premier Functional Cell Biology Company
-
Berkeley Lights to Showcase its New Beacon® System Workflow to Access Broad B Cell Diversity to Rapidly Identify High-Value Rabbit Monoclonal Antibodies at 2022 Antibody Engineering & Therapeutic
-
Berkeley Lights Accelerating Antibody Discovery with Launch of Rabbit Memory B Cell Workflow
-
Monash University Implements Antibody Discovery Application by Utilizing the Berkeley Lights Beacon® Platform
-
Berkeley Lights Reports Third Quarter 2022 Financial Results
-
Berkeley Lights to Host Upcoming Investor Day
-
Berkeley Lights to Report Third Quarter 2022 Financial Results on November 8, 2022
-
Berkeley Lights to Participate in the BioProcess International 2022 Conference
-
Berkeley Lights Announces Appointment of Scott Chaplin as Chief Legal Officer
-
Berkeley Lights Reports Second Quarter 2022 Financial Results
-
Berkeley Lights and the Jaime Leandro Foundation Announce the Discovery, Functional Characterization, and Recovery of a Patient-Derived T cell Receptor Sequence Against a Cancer Neoantigen
-
Berkeley Lights to Participate in the Cambridge Healthtech Institute's 14th Annual Bioprocessing Summit Conference
-
Berkeley Lights Announces Appointment of Dr. Rolando Brawer as Executive Vice President, Strategy & Corporate Development
-
Berkeley Lights and Aanika BioSciences Reach Strategic Partnership Milestone By Identifying A Commercially Viable Antimicrobial Peptide
-
Berkeley Lights Announces Mehul Joshi as New Chief Financial Officer
-
Berkeley Lights to Report Second Quarter 2022 Financial Results on August 9, 2022
-
Berkeley Lights to Participate at the 27th European Society for Animal Cell Technology Meeting
-
Curia Adopts the Berkeley Lights Platform to Expand its Antibody Discovery Capabilities
-
Berkeley Lights Reports First Quarter 2022 Financial Results
-
Berkeley Lights to Participate in the 18th Annual PEGS Boston Conference & Expo
-
Berkeley Lights to Report First Quarter 2022 Financial Results on May 9, 2022
-
Berkeley Lights Announces Appointment of Lucas S. Vitale as Chief Human Resources Officer
-
Berkeley Lights and Vestaron Announce Partnership to Develop Pesticidal Peptides Utilizing Proprietary High-Throughput, Functional Screening Service
-
Berkeley Lights Announces Appointment of Dr. Siddhartha Kadia as Chief Executive Officer
-
Berkeley Lights to Showcase its Optofluidic Discovery Technology at 2022 Festival of Biologics Conference
Back to BLI Stock Lookup